MIT-Takeda Program heads into fourth year with crop of 10 new projects
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.
Startups led by MIT mechanical engineers offer health care solutions
Companies founded by MechE faculty and alumni solve a variety of health care challenges, from better drug delivery to robotic surgery.
Professor Emeritus Richard Wurtman, influential figure in translational research, dies at 86
Longtime MIT professor of neuroscience led research behind 200 patents, laying the groundwork for numerous medical products.
The economics of missed opportunities
Danielle Li takes a close look at scientific practices and organizational decisions — and provides data about improving them.
Artificial intelligence model finds potential drug molecules a thousand times faster
A geometric deep-learning model is faster and more accurate than state-of-the-art computational models, reducing the chances and costs of drug trial failures.
New light-powered catalysts could aid in manufacturing
When coated onto plastic tubing, the catalysts could act on chemicals flowing through, helping to synthesize drugs and other compounds.
Can artificial intelligence overcome the challenges of the health care system?
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
A smarter way to develop new drugs
A new artificial intelligence technique only proposes candidate molecules that can actually be produced in a lab.
Reversing hearing loss with regenerative therapy
MIT spinout Frequency Therapeutics’ drug candidate stimulates the growth of hair cells in the inner ear.
From bench to biotech
Life sciences class brings biotech industry experience into the classroom with part-time internships for graduate students.
Artificial intelligence system rapidly predicts how two proteins will attach
The machine-learning model could help scientists speed the development of new medicines.
Taking some of the guesswork out of drug discovery
A deep learning model rapidly predicts the 3D shapes of drug-like molecules, which could accelerate the process of discovering new medicines.
New 10-minute test detects Covid-19 immunity
Paper-based blood test developed by SMART researchers can rapidly determine the presence of SARS-CoV-2 neutralizing antibodies.
MIT Sloan and Bayer team up to cultivate digital intrapreneurship capability
Corporate innovation leaders at Bayer engage MIT Sloan Executive Education in a transformational data science and intrapreneurship program.
Landmark Bio, a biomanufacturing facility co-founded by MIT, breaks ground in Watertown Arsenal
Public-private partnership aims to advance development and production of medical treatments.